ArticleThe European respiratory journal2022

Bedaquiline can act as core drug in a standardised treatment regimen for fluoroquinolone-resistant rifampicin-resistant tuberculosis.

Tom Decroo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.